Company page
Gensight Biologics Sa
Gensight Biologics Sa is a public company listed under the ticker SIGHT on the French market. The company has a market capitalization of approximately €22.69 million. Gensight focuses on developing innovative gene therapies for retinal diseases.
- Ticker
- SIGHT:EURONEXT
- Asset type
- Stock
- Market cap
- $22.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR